Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.
Researchers developed and assessed logistic prediction models for the detection of advanced neoplasia (AN) and colorectal cancer (CRC).
Researchers sought to determine the prevalence of cardiovascular disease, cirrhosis, metabolic diseases, and chronic kidney disease in lean vs overweight or obese NAFLD.
Researchers evaluated the effects of antibiotic exposure, specifically cumulative use, timing of use, and the association with older-onset IBD.
Researchers compared the effectiveness of tofacitinib and vedolizumab among patients with UC who had experienced anti-TNF failure.
A team of researchers analyzed the safety, efficacy, and tolerability of seladelpar in patients with compensated liver cirrhosis resulting from primary biliary cholangitis.
No significant difference in SRE risk on the basis of intravenous bisphosphonate dosing was observed for patients with newly diagnosed multiple myeloma.
This case study examines 2 patients with relapsing remitting multiple sclerosis, under dimethyl fumarate treatment, who developed severe herpes zoster infection.
A team of investigators conducted a prospective, multicenter study to assess the safety of H pylori eradication therapy in adolescent students.
The authors propose evaluating which aspects of previous policy and practices for OUD should resume and which aspects of current policy and practice exemptions should continue.
